“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two of the best biotech IPOs to watch from here. One firm is a leader in developing a potential COVID-19 vaccine (and also has a number of other promising treatment candidates in clinical trials), and the other is focused on developing therapies for cancer and rare diseases. For more on these two biotech IPOs to watch, CLICK HERE.